Protagonist Therapeutics Inc
Closed
SectorHealthcare
133.32 1.98
Overview
Share price change
24h
Min
128.41
Max
131.59
Income | -82M 3.8M |
|---|---|
Sales | 49M 56M |
P/E Sector Avg | 131.197 60.149 |
EPS | 0.05 |
Profit margin | 6.711 |
Employees | 131 |
EBITDA | 46M 2.7M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | -4.1% downside |
Next Earnings | 4 sie 2026 |
|---|
Market Cap | 2.1B 8.5B |
|---|---|
Previous open | 131.34 |
Previous close | 133.32 |
News Sentiment
By Acuity
50%
50%
172 / 342 Ranking in Healthcare
Protagonist Therapeutics Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Protagonist Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 124.56 USD -4.1%
High 151 USD
Low 100 USD
Based on 9 Wall Street analysts offering 12 month price targets forProtagonist Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$